NEW YORK (GenomeWeb News) – Cellular analysis toolmaker Fluxion Biosciences said yesterday that it has hired Bucher Biotec to sell and distribute its research tools to drug developers in Switzerland.
 
Under the exclusive agreement, Basel-based Bucher will distribute Fluxion’s BioFlux cell imaging analysis tools.
 
The BioFlux 200 is used in cell adhesion and microbial biofilm studies and allows researchers to study live cells and biofilms under controlled conditions.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.